The patient from Subgroup 2 had positive IgG antibodies (1.73) and negative IgA antibodies after the vaccination, and after the second event (infection), his IgG antibodies increased (6.92), however, his IgA response remained undetected. This evidence concerns the gene CD79A and infection.